Vertex Pharmaceuticals - Lomibuvir & Merimepodib Inhibitors - Ownership and Business Overview

Life ScienceCompany

Vertex Pharmaceuticals - Lomibuvir & Merimepodib Inhibitors Ownership

Who owns Vertex Pharmaceuticals - Lomibuvir & Merimepodib Inhibitors?

Vertex Pharmaceuticals - Lomibuvir & Merimepodib Inhibitors is owned by Trek Therapeutics PBC. It was acquired on July 26, 2016.

Vertex Pharmaceuticals - Lomibuvir & Merimepodib Inhibitors Business Overview

Where is Vertex Pharmaceuticals - Lomibuvir & Merimepodib Inhibitors headquartered?

Vertex Pharmaceuticals - Lomibuvir & Merimepodib Inhibitors is headquartered in Boston, Massachusetts.

What sector is Vertex Pharmaceuticals - Lomibuvir & Merimepodib Inhibitors in?

Vertex Pharmaceuticals - Lomibuvir & Merimepodib Inhibitors is a life science company.

Life Science M&A Summary in 2016

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2016. The largest life science acquisition in 2016 was Baxalta - which was acquired by Shire for $32.0B.

Join Mergr to view all 296 acquisitions of life science companies in 2016, including 34 acquisitions by private equity firms, and 262 by strategics.

Vertex Pharmaceuticals - Lomibuvir & Merimepodib Inhibitors

Boston, Massachusetts
United States,

Vertex Pharmaceuticals - Lomibuvir & Merimepodib Inhibitors is a development and commercialization rights to treat infectious disease with lomibuvir (VX-222), a non-nucleoside inhibitor of the HCV NS5B polymerase and merimepodib (VX-497), an inhibitor of inosine monosphosphate dehydrogenase with broad-spectrum antiviral properties.


Company Summary

SECTOR

Life Science

 Subscribe to unlock this and 209,748
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Vertex Pharmaceuticals - Lomibuvir & Merimepodib Inhibitors

Massachusetts Companies , Life Science Companies , United States Companies , Massachusetts Life Science Companies , Massachusetts Life Science with Acquisitions , Massachusetts Life Science with Divestitures

Related Lists for Massachusetts Companies

Largest Massachusetts Companies , Acquisitive Massachusetts Companies , Recently Acquired Massachusetts Companies , Recently Sold Massachusetts Companies , Private Massachusetts Companies , Public Massachusetts Companies , Acquired Massachusetts Companies , PE Backed Massachusetts Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for United States Companies

Largest United States Companies , Acquisitive United States Companies , Recently Acquired United States Companies , Recently Sold United States Companies , Private United States Companies , Public United States Companies , Acquired United States Companies , PE Backed United States Companies
Mergr

Product

Company

Legal